Pricing Log in Create free account

Immunic, Inc. (IMUX) vs Tenaya Therapeutics, Inc. (TNYA)

Immunic, Inc. and Tenaya Therapeutics, Inc. are both Biotechnology companies. Immunic, Inc. and Tenaya Therapeutics, Inc. are of similar size ($96.9M and $91.6M). Across the 8 metrics below, Immunic, Inc. leads on 4 and Tenaya Therapeutics, Inc. on 4.

Valuation

Metric IMUX TNYA Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 2.32 1.16 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (62.84%) (143.24%) (33.15%)
Free cash flow yield (29.71%) (65.32%) (25.50%)

Profitability

Metric IMUX TNYA Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (138.17%) (121.86%) (56.36%)
Return on assets (101.15%) (95.61%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric IMUX TNYA Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 38.00% 54.96% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IMUX TNYA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 5.05 4.52 4.72
Net debt to EBITDA 0.15 1.19 0.96

Dividend

Metric IMUX TNYA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric IMUX TNYA Biotechnology median
Market cap 96.87m 91.57m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack